We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 49

Bayer v. Canada

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • May 28 2009

The Court of Appeal dismissed Bayer’s appeal, thus affirming the refusal to list the patent on the Patent Register

Lundbeck v. Ratiopharm and Cobalt

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • May 28 2009

The Court of Appeal upheld the decision of the applications judge who struck the applications for judicial review

Eli Lilly v. Canada (Minister of Health)

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • May 28 2009

Eli Lilly had submitted patent lists seeking to add the newly issued patent at issue to the Patent Register with respect to several supplemental new drug submissions

Novopharm Limited v. Eli Lilly Canada Inc

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • May 28 2009

The Court of Appeal dismissed the appeal of the generic company from a decision of the motions judge refusing to dismiss the proceeding as a whole

Aventis v. Pharmascience; motion to set aside a previous order of prohibition; 2009 FC 915; ramipril; September 15, 2009

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • September 30 2009

Pharmascience had previously sent an Notice of Allegation (NOA) with respect to a patent to Aventis, resulting in a full hearing and appeal, concluding with an order of prohibition

Janssen-Ortho v. Apotex; motion for a stay; 2009 FCA 250; tramadol and acetaminophen; August 20, 2009

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • September 30 2009

In the Courts below, Apotex brought a motion to dismiss the application

Federal Court of Appeal upholds denial of innovator profits and refuses to grant damages for future lost market share in first case under s. 8 of the PM(NOC) Regulations

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • June 5 2009

In September 2008, the Federal Court released its first decision interpreting s. 8 of the PM(NOC) Regulations

Solvay v. Canada (Minister of Health)

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • March 4 2009

The Court upheld the decision of the Minister refusing to list a patent on the Patent Register

G.D. Searle v. Canada (Minister of Health)

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • March 4 2009

The Minister of Health removed a patent from the Patent Register on the basis that it was ineligible for listing

Novopharm v. Eli Lilly

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • March 4 2009

The Court dismissed a motion by the Canadian Generic Pharmaceutical Association (CGPA) requesting leave to intervene in Novopharm's appeal of a decision of the Federal Court